<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Journal of Psychiatry and Psychological Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="epub">3107-9024</issn>
      <abbrev-journal-title abbrev-type="publisher">JPPC</abbrev-journal-title>
      <publisher>
        <publisher-name>Confmeets Publishing, an imprint of Conve International Pvt Ltd</publisher-name>
        <publisher-loc>Visakhapatnam, Andhra Pradesh, India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Mini Review</subject>
        </subj-group>
      </article-categories>
      <article-id pub-id-type="doi">10.67238/jppc.2026.v2.15</article-id>
      <article-id pub-id-type="publisher-id">JPPC-26-8492</article-id>
      <title-group>
        <article-title>Addiction Services and Challenges in the United Arab Emirates: A Comprehensive Mini Review</article-title>
      </title-group>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>08</month>
        <year>2026</year>
      </pub-date>
      <volume>2</volume>
      <issue>2</issue>
      <fpage>178</fpage>
      <lpage>181</lpage>
      <counts>
        <page-count count="4"/>
      </counts>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>06</month>
          <year>2026</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>07</month>
          <year>2026</year>
        </date>
        <date date-type="pub">
          <day>04</day>
          <month>08</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0/" license-type="open-access">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="https://www.confmeets.com/journals/jppc/articles/JPPC-26-8492-1.pdf"/>
      <aff id="aff1">
        <institution-wrap>
          <institution>Medical Director and Consultant Psychiatrist, Thrive Wellbeing Centre, Dubai, United Arab Emirates</institution>
        </institution-wrap>
      </aff>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shishodia</surname>
            <given-names>Ash</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <abstract>
        <p>Substance use disorders (SUDs) are increasingly recognized as chronic, relapsing medical conditions with significant social, economic, and health consequences. Although historically characterized by low prevalence due to cultural, religious, and legal deterrents, recent evidence indicates rising misuse of prescription medications, synthetic substances, and alcohol in the United Arab Emirates (UAE). Over the past decade, the UAE has implemented major reforms, including rehabilitative legal pathways and expansion of specialized treatment services. Despite these advances, persistent challenges remain, including stigma, workforce shortages, fragmented care pathways, and limited aftercare. This review synthesizes current epidemiological trends, policy developments, treatment infrastructure, and systemic barriers, and proposes evidence-based recommendations aligned with international standards to support a comprehensive, culturally responsive addiction care framework.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Substance Use Disorders</kwd>
        <kwd>United Arab Emirates</kwd>
        <kwd>Addiction Services</kwd>
        <kwd>Drug Rehabilitation</kwd>
        <kwd>Addiction Policy</kwd>
        <kwd>Mental Health</kwd>
        <kwd>Stigma</kwd>
        <kwd>Recovery-Oriented Care</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Substance use disorders (SUDs) constitute one of the most pressing global public health challenges, contributing substantially to morbidity, mortality, and socioeconomic burden. As noted in the original manuscript, “Substance use disorders are increasingly recognized as chronic, relapsing medical conditions with profound social, economic, and health consequences.” This framing aligns with contemporary models that conceptualize addiction as a chronic brain disease requiring long term, integrated care rather than episodic or punitive responses [1-2].</p>
      <p>Globally, rapid urbanization, increased availability of synthetic drugs, and shifting sociocultural norms have contributed to rising prevalence rates [3-4]. The UNODC World Drug Report 2024 highlights escalating misuse of synthetic cannabinoids, amphetamine type stimulants, and prescription medications across multiple regions. These trends are mirrored in the UAE, a rapidly developing nation with a diverse expatriate population and increasing exposure to global drug markets.</p>
      <p>Historically, substance use in the UAE remained low due to strong religious norms, cohesive family structures, and strict legislation. However, recent reports indicate a gradual increase in both licit and illicit drug consumption, particularly among young males [5-6]. Prescription medications such as tramadol, pregabalin, and benzodiazepines have become substances of concern, alongside synthetic cannabinoids and alcohol misuse among expatriates [7-8].</p>
      <p>Despite growing political commitment and substantial investment in treatment infrastructure, the literature reveals several gaps. Existing studies often examine isolated components, such as legal reforms, treatment centre operations, or youth perceptions without integrating these elements into a cohesive national overview. There is a need for a consolidated synthesis of epidemiological trends, policy developments, service structures, and systemic barriers specific to the UAE.</p>
    </sec>
    <sec>
      <title>REVIEW CONTENT</title>
      <p>This mini review addresses this gap by providing a structured, evidence-based analysis of addiction services in the UAE, comparing them with international best practices, and identifying priority areas for future development. The goal is to support policymakers, clinicians, and researchers in advancing a comprehensive, culturally responsive addiction strategy.</p>
      <sec>
        <title>Epidemiology and Emerging Trends</title>
        <p>
          <bold>Substances of Concern</bold>
        </p>
        <p>Patterns of substance use in the UAE reflect global shifts toward synthetic and pharmaceutical substances:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prescription medications (tramadol, pregabalin, benzodiazepines) are frequently misused due to accessibility and perceived safety [7,9].</p>
          </list-item>
          <list-item>
            <p>Synthetic cannabinoids and amphetamine type stimulants have gained popularity among younger users [3,10].</p>
          </list-item>
          <list-item>
            <p>Alcohol misuse remains a concern among expatriates despite regulatory restrictions [8,11].</p>
          </list-item>
          <list-item>
            <p>Illicit substances such as methamphetamine and heroin appear in forensic reports, though at lower prevalence [5].</p>
          </list-item>
        </list>
      </sec>
      <sec>
        <title>Co-occurring Mental Health Conditions</title>
        <p>Dual diagnoses involving depression, anxiety, and trauma related disorders are increasingly documented, complicating treatment and recovery [12-13]. This aligns with global evidence demonstrating high comorbidity between SUDs and psychiatric disorders.</p>
        <p>
          <bold>Sociocultural Influences</bold>
        </p>
        <p>Stigma remains a major barrier to help seeking, particularly among Emirati families where addiction is often viewed as a moral failing [6]. The manuscript notes that “stigma remains one of the most significant obstacles to treatment engagement.” Global evidence confirms that stigma reduces treatment entry, retention, and recovery outcomes [14-15].</p>
        <p>
          <bold>Legal and Policy Developments</bold>
        </p>
        <p>The UAE has undertaken significant legislative reforms to modernize its approach to addiction. Federal Decree Law No. 30 of 2021 represents a pivotal shift, introducing rehabilitative alternatives for first time offenders and expanding judicial discretion to support treatment over incarceration [16].</p>
        <p>Key policy features include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mandatory referral to accredited treatment centres</p>
          </list-item>
          <list-item>
            <p>Reduced penalties for individuals completing rehabilitation</p>
          </list-item>
          <list-item>
            <p>Emphasis on prevention, early intervention, and community education</p>
          </list-item>
          <list-item>
            <p>Alignment with WHO recommendations advocating public health–based responses [17].</p>
          </list-item>
        </list>
        <p>These reforms reflect a global movement toward treating addiction as a chronic medical condition rather than a criminal act [18-19].</p>
        <p>
          <bold>Treatment and Rehabilitation Infrastructure</bold>
        </p>
        <p>
          <italic><bold>National Rehabilitation Centre (NRC)</bold> </italic>
        </p>
        <p>The NRC in Abu Dhabi serves as the country’s flagship addiction treatment facility, offering:</p>
        <list list-type="bullet">
          <list-item>
            <p>Medically supervised detoxification</p>
          </list-item>
          <list-item>
            <p>Individual and group psychotherapy</p>
          </list-item>
          <list-item>
            <p>Family interventions</p>
          </list-item>
          <list-item>
            <p>Relapse prevention programs</p>
          </list-item>
          <list-item>
            <p>Continuing care and follow up</p>
          </list-item>
        </list>
        <p>The NRC also contributes to research, workforce training, and policy development [20].</p>
        <p>
          <italic><bold>Al Amal Psychiatric Hospital</bold> </italic>
        </p>
        <p>Located in Dubai, Al Amal provides:</p>
        <list list-type="bullet">
          <list-item>
            <p>Detoxification services</p>
          </list-item>
          <list-item>
            <p>Outpatient follow up</p>
          </list-item>
          <list-item>
            <p>Court mandated assessments</p>
          </list-item>
          <list-item>
            <p>Psychiatric care for co-occurring disorders</p>
          </list-item>
        </list>
        <p>
          <bold>Private and NGO Services</bold>
        </p>
        <p>Private centres and NGOs offer outpatient counselling, harm reduction education, and family support. Accessibility varies due to cost, insurance limitations, and geographic distribution.</p>
        <p>
          <italic><bold>Integration Challenges</bold> </italic>
        </p>
        <p>Despite progress, addiction services remain fragmented, with limited coordination between primary care, mental health services, and social support systems [21]. This fragmentation contributes to treatment dropout and relapse.</p>
      </sec>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>The UAE has demonstrated strong political commitment to addressing addiction through legislative reform, investment in specialized services, and alignment with international standards. However, deeper analysis reveals important contrasts between UAE practices and international benchmarks.</p>
      <sec>
        <title>Comparison with International Models</title>
        <p>Countries with mature addiction systems such as Portugal, Canada, and the UKhave adopted integrated, recovery oriented frameworks emphasizing:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stepped care models</p>
          </list-item>
          <list-item>
            <p>Harm reduction services</p>
          </list-item>
          <list-item>
            <p>Integrated mental health–addiction clinics</p>
          </list-item>
          <list-item>
            <p>Peer support networks</p>
          </list-item>
          <list-item>
            <p>Community based rehabilitation</p>
          </list-item>
        </list>
        <p>These models are supported by robust evidence [2-23]. In contrast, the UAE’s system remains more centralized and medically oriented, with limited community based services and minimal harm reduction infrastructure [24].</p>
        <p>
          <bold>Workforce and Training Gaps</bold>
        </p>
        <p>The UAE faces shortages of addiction psychiatrists, psychologists, social workers, and peer support specialists. Expanding postgraduate training programs and certification pathways aligned with WHO standards is essential [25-26].</p>
        <p>
          <bold>Sociocultural and Legal Considerations</bold>
        </p>
        <p>Stigma remains a major barrier to help seeking. International evidence shows that culturally tailored public education campaigns, school based prevention programs, and family centred interventions can reduce stigma and promote early intervention [15,27].</p>
      </sec>
    </sec>
    <sec>
      <title>CONCLUSION</title>
      <p>This review highlights that the UAE has made substantial progress in reframing addiction as a public health issue, modernizing legislation, and expanding specialized treatment services. However, persistent challenges including stigma, workforce shortages, fragmented services, and limited aftercare underscore the need for a comprehensive national addiction strategy.</p>
      <p>
        <bold>Key Findings</bold>
      </p>
      <list list-type="bullet">
        <list-item>
          <p>Substance use patterns increasingly mirror global trends</p>
        </list-item>
        <list-item>
          <p>Legislative reforms have shifted the national approach toward rehabilitation</p>
        </list-item>
        <list-item>
          <p>Specialized services provide high-quality care but remain insufficient relative to population needs</p>
        </list-item>
        <list-item>
          <p>Stigma and fragmented care pathways impede recovery outcomes</p>
        </list-item>
      </list>
      <sec>
        <title>Practical Implications</title>
        <list list-type="bullet">
          <list-item>
            <p>Policymakers should prioritize integrated, multisectoral strategies</p>
          </list-item>
          <list-item>
            <p>Clinicians require expanded training opportunities in addiction medicine</p>
          </list-item>
          <list-item>
            <p>Community based services and peer support networks are essential for long term recovery</p>
          </list-item>
        </list>
      </sec>
      <sec>
        <title>Policy Recommendations</title>
        <list list-type="bullet">
          <list-item>
            <p>Establish a national addiction observatory</p>
          </list-item>
          <list-item>
            <p>Expand MAT and harm reduction initiatives</p>
          </list-item>
          <list-item>
            <p>Develop culturally tailored stigma reduction campaigns</p>
          </list-item>
          <list-item>
            <p>Strengthen reintegration pathways</p>
          </list-item>
          <list-item>
            <p>Enhance coordination between healthcare sectors</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec>
      <title>DATA AND SURVEILLANCE LIMITATIONS</title>
      <p>The absence of comprehensive national epidemiological data limits service planning and outcome evaluation. Establishing a national addiction observatory would significantly enhance evidence based policymaking [17,28].</p>
    </sec>
    <sec>
      <title>FUTURE DIRECTIONS</title>
      <p>To align more closely with international best practices, the UAE may consider:</p>
      <list list-type="bullet">
        <list-item>
          <p>Developing community based recovery centres</p>
        </list-item>
        <list-item>
          <p>Expanding medication assisted treatment (MAT) programs [29].</p>
        </list-item>
        <list-item>
          <p>Implementing national prevention campaigns</p>
        </list-item>
        <list-item>
          <p>Strengthening integration between primary care and mental health services</p>
        </list-item>
        <list-item>
          <p>Establishing national data systems</p>
        </list-item>
        <list-item>
          <p>Enhancing vocational rehabilitation and reintegration programs</p>
        </list-item>
      </list>
    </sec>
    <sec>
      <title>FUTURE RESEARCH</title>
      <list list-type="bullet">
        <list-item>
          <p>Longitudinal studies on substance use trends</p>
        </list-item>
        <list-item>
          <p>Evaluations of treatment outcomes</p>
        </list-item>
        <list-item>
          <p>Research on culturally adapted interventions</p>
        </list-item>
        <list-item>
          <p>Studies examining the impact of legal reforms</p>
        </list-item>
      </list>
    </sec>
    <sec>
      <title>CONFLICT OF INTEREST STATEMENT</title>
      <p>The author declares no conflicts of interest.</p>
    </sec>
    <sec>
      <title>ACKNOWLEDGEMENTS</title>
      <p>None</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>McLellan AT, Lewis DC, O'Brien CP, Kleber PH. Drug Dependence, a Chronic Medical Illness. The Science of Mental Health: Compulsive disorder and Tourette's syndrome. 2001;284(13):29</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Han B, Volkow ND, Jones CM, Dowell D, Baldwin G, et al. Polysubstance use disorders among US adults. Molecular Psychiatry. 2026 :1-3</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Canton H. United Nations Office on drugs and crime—UNODC. InThe Europa directory of international organizations 2021 2021 (pp. 240-244). Routledge</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet. 2012 ;379(9810):55-70</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>National Rehabilitation Centre (NRC) (2022). Annual Report. Abu Dhabi: NRC Publications</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Alhyas L, Al Ozaibi N, Elarabi H, El-Kashef A, Wanigaratne S, et al. Adolescents’ perception of substance use and factors influencing its use: a qualitative study in Abu Dhabi. JRSM open. 2015;6(2):2054270414567167</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Al Marzooqi F, Elkashef A &amp; Al Ghaferi H (2020). Drug addiction treatment and rehabilitation services in the United Arab Emirates: Challenges and solutions. Eastern Mediterranean Health Journal, 26(4), 432–438</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>World Health Organization. Global status report on alcohol and health 2018. World Health Organization; 2018</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Tamburello AC. Misuse of noncontrolled medications. Oxford Textbook of Correctional Psychiatry. 2025:185</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Peacock A, et al. (2022). Global patterns of amphetamine‑type stimulant use. Addiction, 117(6), 1600–1612</mixed-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <mixed-citation>Carvajal F, Lerma-Cabrera JM . Alcohol consumption among adolescents—implications for public health. Topics in public health. 2015:51-76</mixed-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <mixed-citation>Volkow ND, Koob G. Brain disease model of addiction: why is it so controversial?. The Lancet Psychiatry. 2015;2(8):677-9</mixed-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <mixed-citation>Zhao X, Liu L, Zhao P, Jiang W, Nahata M. The Global Burden and Trends of Mental Disorders and Substance Use Disorders Among Adolescents and Young Adults: Findings from the Global Burden of Disease Study 1990–2021. Available at SSRN 4957498. 2024</mixed-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <mixed-citation>Livingston JD et al. (2020). Stigma and substance use disorders: A systematic review. Drug and Alcohol Dependence, 204, 107502</mixed-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <mixed-citation>Tsai, A. C., et al. (2021). Public stigma toward people with substance use disorders: A global perspective. The Lancet Public Health, 6(1), e9–e17</mixed-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <mixed-citation>Al Zaabi LA, Islam R, Rahman NA. Transnational Drug Crime: A Case Study of the United Arab Emirates’ Response to Emerging Threats. International Journal of Aquatic Research and Environmental Studies. 2026;6(S3):66-75</mixed-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <mixed-citation>Citaristi I. World Health Organization—WHO. InThe Europa Directory of International Organizations 2022 2022(pp. 380-395). Routledge</mixed-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <mixed-citation>Saitz, R. (2014). Integrating addiction care into general medicine. New England Journal of Medicine, 371(7), 591–593</mixed-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <mixed-citation>Griffiths P, Sedefov R, Gallegos A, &amp; Lopez, D. (2010). How globalization and market innovation challenge conventional drug policy. Drugs: Education, Prevention and Policy, 17(2), 101–111</mixed-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <mixed-citation>Al Ghaferi H, Ali A &amp; Wanigaratne S (2017). Addiction in the Arab world: An overview. Arab Journal of Psychiatry, 28(2), 93–102</mixed-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <mixed-citation>Becker WC &amp; Fiellin DA (2020). Provider challenges in opioid use disorder treatment. Annals of Internal Medicine, 173(1), 70–72</mixed-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <mixed-citation>Humphreys K &amp; Saitz R (2019). Should addiction treatment be integrated into primary care?. New England Journal of Medicine, 381(6), 501–503</mixed-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <mixed-citation>Madden L, et al. (2021). Recovery‑oriented systems of care: International evidence. Addiction, 116(10), 2603–2615</mixed-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <mixed-citation>Karamouzian M, et al. (2022). Harm reduction in the Middle East: Opportunities and challenges. International Journal of Drug Policy, 99, 103455</mixed-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <mixed-citation>Priester, M. A., et al. (2020). Addiction workforce development: A global review. Journal of Substance Abuse Treatment, 108, 1–10</mixed-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <mixed-citation>Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Substance abuse. 2016;37(4):635-41</mixed-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <mixed-citation>Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. International Journal of Drug Policy. 2010 ;21(3):202-7</mixed-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <mixed-citation>Rehm J, et al. (2021). Improving national drug monitoring systems: Lessons from Europe. Addiction, 116(12), 3383–3394</mixed-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <mixed-citation>Larney, S., et al. (2020). The effectiveness of opioid agonist treatment: Updated systematic review. The Lancet, 395(10228), 156–167</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
